⚖️Commission Issues Remedial Orders Against Xiamen for Patent Infringement
Notice is hereby given that the U.S. International Trade Commission ("Commission") has determined to issue a limited exclusion order and cease and desist order against defaulting respondent Xiamen Dirongte Trading Co., Ltd. of Xiamen City, China ("Xiamen"), the sole respondent in this investigation. The Commission has also determined to impose a bond equal to one hundred percent (100%) of the entered value of the infringing products imported during the period of Presidential review. The investigation is hereby terminated.
Learn More🔧Investigation of Boiler Protection Patent Infringement by ITC
Notice is hereby given that a complaint was filed with the U.S. International Trade Commission on May 14, 2025, under section 337 of the Tariff Act of 1930, as amended, on behalf of ARPC LLC and Paul Unmack of Butte, Montana. A supplement was filed on May 23, 2025. The complaint alleges violations of section 337 based upon the importation into the United States, the sale for importation, and the sale within the United States after importation of certain boiler protection for absorption refrigeration systems and components thereof by reason of the infringement of certain claims of U.S. Patent No. 8,056,360. The complaint further alleges that an industry in the United States exists as required by the applicable Federal Statute. The complainants request that the Commission institute an investigation and, after the investigation, issue a general exclusion order, or in the alternative a limited exclusion order, and cease and desist orders.
Learn More🚫Limited Exclusion Order on Dermatological Treatment Devices
Notice is hereby given that the U.S. International Trade Commission has found a violation of section 337 and has determined to issue: a limited exclusion order prohibiting the unlicensed importation of certain dermatological treatment devices and components thereof that infringe one or more of claims 1, 9, and 22 of U.S. Patent No. 9,480,836 ("the '836 patent"); claims 11 and 16 of U.S. Patent No. 9,320,536 ("the '536 patent"); claim 14 of U.S. Patent No. 9,775,774 ("the '774 patent"); and claims 5, 13, and 18 of U.S. Patent No. 10,869,812 ("the '812 patent"); cease and desist orders against Respondents EndyMed Medical Ltd. of Caesarea, Israel; EndyMed Medical, Ltd. of New York, New York; and EndyMed Medical, Inc. of Freehold, New Jersey (collectively, "EndyMed"); and set a bond in the amount of eighty-five percent (85%) of the entered value of the EndyMed Pure, and seventy percent (70%) of the entered value of the EndyMed Pro infringing products imported during the period of Presidential review. The investigation is terminated with respect to these four patents. The Commission has also determined to reverse the presiding administrative law judge's ("ALJ") finding that asserted claims 4, 6, and 7 of U.S. Patent No. 11,406,444 ("the '444 patent") are indefinite, remand the investigation to the ALJ with respect to that patent consistent with the concurrently issued Commission opinion and remand order, and extend the target date for completion of the investigation.
Learn More🛴USITC Notice on Motorized Self-Balancing Vehicles Investigation
Notice is hereby given that the U.S. International Trade Commission has determined not to review an initial determination ("ID") (Order No. 10) of the presiding administrative law judge ("ALJ"), granting an unopposed motion to amend the complaint and notice of investigation ("NOI") by adding a new respondent, Zhejiang TaoTao Vehicles Co., Ltd. ("Tao Motor").
Learn More📦ITC Notice on Composite Bulk Container Patent Investigation
Notice is hereby given that the U.S. International Trade Commission has determined not to review an initial determination ("ID") (Order No. 10) of the presiding Chief Administrative Law Judge ("Chief ALJ") granting an unopposed motion to amend the complaint and notice of investigation to change the address of one of the respondents.
Learn More⚖️Notice of ITC Investigation
Notice is hereby given that the U.S. International Trade Commission has determined not to review an initial determination ("ID") of the presiding administrative law judge ("ALJ") granting a motion to amend the complaint and notice of investigation to add seven additional respondents.
Learn More⚖️Limited Exclusion Orders and Cease and Desist Rulings on Hydrodermabrasion Systems
Notice is hereby given that the U.S. International Trade Commission ("Commission") has determined to issue a limited exclusion order ("LEO") barring entry of certain hydrodermabrasion systems and components thereof by or on behalf of respondents Medical Purchasing Resource, LLC, Bio-Infusions USA Inc., MIRAmedtech UG, eMIRAmed USA, LLC, and MIRAmedtech SP. Z.O.O. (collectively, "Defaulting Respondents"); and cease and desist orders ("CDOs") against the Defaulting Respondents. The investigation is terminated.
Learn More📡Investigation Notice on Integrated Circuits and Patent Infringement
Notice is hereby given that a complaint was filed with the U.S. International Trade Commission on April 18, 2025, under section 337 of the Tariff Act of 1930, as amended, on behalf of Onesta IP, LLC of Wayne, Pennsylvania. A letter supplementing the complaint was filed on May 8, 2025. The complaint, as supplemented, alleges violations of section 337 based upon the importation into the United States, the sale for importation, and the sale within the United States after importation of certain integrated circuits, electronic devices containing the same, and components thereof by reason of the infringement of certain claims of U.S. Patent No. 8,854,381 ("the '381 patent"); U.S. Patent No. 9,519,943 ("the '943 patent"); U.S. Patent No. 7,717,350 ("the '350 patent"); U.S. Patent No.11,741,019 ("the '019 patent"); U.S. Patent No. 11,841,803 ("the '803 patent"); and U.S. Patent No. 9,116,809 ("the `809 patent"). The complaint further alleges that an industry in the United States exists or is in the process of being established as required by the applicable Federal Statute. The complainant requests that the Commission institute an investigation and, after the investigation, issue a limited exclusion order and cease and desist orders.
Learn More⚖️Investigation into Balloon Dilation Device Patent Infringement Announced
Notice is hereby given that a complaint was filed with the U.S. International Trade Commission on April 18, 2025, under section 337 of the Tariff Act of 1930, as amended, on behalf of Entellus Medical, Inc. of Plymouth, Minnesota, Stryker Corporation of Portage, Michigan, and Stryker Sales, LLC of Portage, Michigan. Supplements to the complaint were filed on April 25 and May 8, 2025. The complaint, as supplemented, alleges violations of section 337 based upon the importation into the United States, the sale for importation, and the sale within the United States after importation of certain balloon dilation devices, systems, and components thereof by reason of the infringement of certain claims of U.S. Patent No. 11,083,878 ("the '878 patent"); U.S. Patent No. 11,090,472 ("the '472 patent"); and U.S. Patent No. 12,274,847 ("the '847 patent"). The complaint further alleges that an industry in the United States exists or is in the process of being established as required by the applicable Federal Statute. The complainants request that the Commission institute an investigation and, after the investigation, issue a limited exclusion order and cease and desist orders.
Learn More📺Investigation Notice
Notice is hereby given that a complaint was filed with the U.S. International Trade Commission on April 11, 2025, under section 337 of the Tariff Act of 1930, as amended, on behalf of Nokia Technologies Oy of Finland and Nokia Corporation of Finland. Supplements to the complaint were filed on April 21, April 24 and May 2, 2025. The complaint, as supplemented, alleges violations of section 337 based upon the importation into the United States, the sale for importation, and the sale within the United States after importation of certain video-capable laptop, desktop computers, handheld computers, tablets, televisions, projectors, and components and modules thereof by reason of the infringement of certain claims of U.S. Patent No. 9,036,701 ("the '701 patent"); U.S. Patent No. 10,536,714 ("the '714 patent"); U.S. Patent No. 11,805,267 ("the '267 patent"); and U.S. Patent No. 8,050,321 ("the '321 patent"). The complaint further alleges that an industry in the United States exists as required by the applicable Federal Statute. The complainants request that the Commission institute an investigation and, after the investigation, issue a limited exclusion order and cease and desist orders.
Learn More